Advertisement
New Zealand markets closed
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NZD/USD

    0.5891
    -0.0014 (-0.24%)
     
  • NZD/EUR

    0.5530
    -0.0014 (-0.25%)
     
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • OIL

    82.94
    +0.21 (+0.25%)
     
  • GOLD

    2,392.80
    -5.20 (-0.22%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,836.17
    -40.88 (-0.52%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,685.34
    -152.06 (-0.85%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • NZD/JPY

    90.9590
    -0.2950 (-0.32%)
     

Don't Buy the Hype: Aurora Cannabis' Transformation Hasn't Worked

Don't Buy the Hype: Aurora Cannabis' Transformation Hasn't Worked

Restructuring and changes in strategy are moves that businesses often deploy when they're facing challenges and headwinds. While Aurora Cannabis (NASDAQ: ACB) has been slashing costs and changing its operations in recent years, the company isn't out of the woods by any stretch. Among the biggest moves that Aurora has made in recent years has been to shift its business more toward medical marijuana.